Intra-arterial peptide receptor radionuclide therapy (IA-PRRT) in patients with SSTR-expressing neuroendocrine neoplasms: short- and long-term safety and efficacy for up to 13 years. [PDF]
Zhang J, Mensel B, Baum RP.
europepmc +1 more source
Health-related quality of life and survival of patients with hepatocellular carcinoma treated with transarterial chemoembolization and Yttrium-90. [PDF]
Bress K +7 more
europepmc +1 more source
Cost-Benefit Analysis of Trans-Arterial Radio-Embolization with Y-90 Glass Microspheres Versus Drug-Eluting Bead Trans-Arterial Chemo-Embolization in Patients with Hepatocellular Carcinoma in Italy. [PDF]
Rognoni C +18 more
europepmc +1 more source
Deep Learning-Based Auto-Segmentation for Liver Yttrium-90 Selective Internal Radiation Therapy. [PDF]
Li J, Choi W, Anne R.
europepmc +1 more source
Individualised dosimetry for holmium-166 RE in patients with unresectable hepatocellular carcinoma; a multi-centre, interventional, non-randomised, non-comparative, open label, phase II study: RHEPaiR. [PDF]
Qurashi M +12 more
europepmc +1 more source
Optimized production of <sup>89</sup>Zr as a medical radioisotope on a variable energy cyclotron and external beam-line. [PDF]
Cocioabă D +7 more
europepmc +1 more source
Is there any effect of hcc location on selective internal radiation therapy with <sup>90</sup>yttrium response? [PDF]
Akgun E +5 more
europepmc +1 more source
Design and optimization of imageable microspheres for locoregional cancer therapy. [PDF]
Kettlewell B +8 more
europepmc +1 more source
Treatment planning for molecular radiotherapy: potential and prospects [PDF]
Aldridge, Matt +14 more
core
SPECT/CT Dosimetry of Bronchial Artery <sup>99m</sup>Tc Macroaggregated Albumin Injection in Pulmonary Malignancies: Feasibility Evaluation of Bronchial Artery <sup>90</sup>Y Radioembolization. [PDF]
Wehrenberg-Klee E +8 more
europepmc +1 more source

